Remove 2024 Remove Confidentiality Remove Intellectual Property Remove Litigation
article thumbnail

Infographic | INTA meeting 2024

Olartemoure Blog

They study past, present, and future trends in branding, covering both the philosophy and economics of trademarks and their interaction with other intellectual property rights and issues such as consumer law, unfair competition, copyright, antitrust, and entertainment. Pava and J. Felipe Acosta, were present.

article thumbnail

2024 Commercial Litigation Outlook and Webinar Series

LexBlog IP

Seyfarth’s Commercial Litigation practice group is pleased to present the fourth annual installment of the Commercial Litigation Outlook, which provides insights on litigation issues and trends to expect in 2024. Dates and details are below.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trade Secrets Protection in India – A Legal Vacuum and the Imperative for Robust Legislation

IP and Legal Filings

In such cases there are some factors that essentially set the company apart, such factor has to be kept confidential and requires protection. According to the World Intellectual Property Organization (WIPO) , “trade secrets are intellectual property rights on confidential information which may be sold or licensed.”

article thumbnail

Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case

SpicyIP

quote from here In a significant order on February 23, 2024, the Delhi High Court, in F- Hoffmann -La Roche Ag & Anr V. The Pertuzumab case is perhaps one significant instance wherein this is poised to deal in such a significant manner in India’s intellectual property adjudication forum. He is not fair game. Find it here.

article thumbnail

Byte – Sized Battles: Challenges of Deploying AI in Trademark Disputes

Intepat

On April 11, 2024 the United States Patent and Trademark Office (USPTO) issued Guidance on the use of Artificial Intelligence Based Tools (“Guidance”) by applying the existing rules and policies to the use of Artificial Intelligence (AI). Asia, however, faces a more complex landscape with diverse legal systems and technological advancements.

article thumbnail

Bevacizumab and Trastuzumab Biosimilars Case Continues, With No End in Sight  

SpicyIP

In this (delayed yet relevant) post, we will discuss the bizarre ongoing Trastuzumab and Bevacizumab litigation before the DHC, focussing on the September 11, 2023 joint judgement passed in two connected cases (Roche versus DCGI, and versus Cadila, respectively). Won’t a Public Interest Litigation Be the Right Way to Address Roche’s Concerns?

article thumbnail

Learning About the Business of Healthcare and Innovation: My Internship Experience at AstraZeneca Canada

IPilogue

This term, I had the amazing opportunity to work at AstraZeneca Canada through Osgoode’s Intellectual Property Law and Technology Intensive Program placement. I remain intrigued to see how the Guidelines, set for implementation in January 2024, may be changed upon receiving consultations. .

Business 110